Entresto included in updated heart failure guidelines
Cardiology groups in the U.S. and Europe have updated their heart failure guidelines to include much-awaited recommendations for Entresto (the combination of valsartan and sacubitril manufactured by Novartis)
http://www.medpagetoday.com/cardiology/cardiobrief/58050
https://content.onlinejacc.org/article.aspx?articleid=2524644
Leave a reply →
